Cribstone Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$103 Hold
88
﹤0.01% 402
2022
Q3
$0 Hold
88
﹤0.01% 474
2022
Q2
$0 Hold
88
﹤0.01% 505
2022
Q1
$0 Hold
88
﹤0.01% 440
2021
Q4
$0 Buy
+88
New ﹤0.01% 406